OTHER ASSETS
Intangible assets, net 328,290 376,922
Assets of discontinued operation - 1,420,996
Total other assets 328,290 1,797,918
TOTAL ASSETS $7,256,262 $10,454,400
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable $152,729 $174,289
Accrued employee compensation 377,190 242,497
Accrued professional fees and other expenses 186,840 150,978
Income taxes payable 4,519 45,962
Deferred taxes - 669,520
Deferred revenue 15,075 4,099
Total current liabilities 736,353 1,287,345
LONG TERM LIABILITIES
Deferred revenue 6,767 9,126
Liabilities of discontinued operation - 1,042,493
Total long term liabilities 6,767 1,051,619
TOTAL LIABILITIES 743,120 2,338,964
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock; 1,000,000 shares authorized;
0 outstanding - -
Common stock, $.01 par value; 20,000,000
shares authorized; 2,192,175 and 2,065,425
shares issued and outstanding 21,922 20,654
Additional paid-in capital 6,284,616 5,347,641
Accumulated other comprehensive income - 1,384,876
Retained earnings 206,604 1,362,265
Total stockholders' equity 6,513,142 8,115,436
TOTAL LI
'/>"/>
| SOURCE Pressure BioSciences, Inc. Copyright©2008 PR Newswire. All rights reserved |